文献速递儿童呼吸

基于肺功能指标诊断有症状儿童哮喘的人群出生队列分析

Diagnosis of asthma in symptomatic children based on measures of lung function: an analysis of data from a population-based birth cohort study.
PubMed 文献 · Lancet Child Adolesc Health · 2017-01-01

该研究利用曼彻斯特哮喘与过敏研究13-16岁随访数据,评估NICE提出的四项肺功能序贯算法中有症状儿童的诊断价值。结果显示,在有症状儿童中该算法诊断准确性差,FEV1:FVC与FeNO与哮喘独立相关,而支气管舒张可逆性不相关,作者不建议在儿童中实施该NICE算法。

要点

  • 有症状儿童中仅少数三项肺功能试验均阳性,43%的现患哮喘儿童三项试验均阴性。
  • FEV1:FVC与FeNO与哮喘独立相关,支气管舒张可逆性不相关。
  • 在有症状儿童中,该算法的诊断准确性差,暂不应在儿童中实施。

核心结论

  • 在有症状儿童中,NICE提出的肺功能序贯算法诊断准确性差,其切点值、检测顺序及支气管舒张可逆性的位置均受到挑战,暂不应在儿童中实施。

研究设计与样本

  • 基于曼彻斯特哮喘与过敏研究的前瞻性人群出生队列,随访至13-16岁,纳入近12个月有喘息、咳嗽或气促且未规律使用吸入糖皮质激素者,采用流行病学定义现患哮喘。

主要发现

  • 624名儿童中支气管舒张可逆性阳性54名(9%),其中仅12名(22%)患现患哮喘。
  • 485名儿童中FeNO≥35 ppb者115名(24%),其中29名(25%)患现患哮喘。
  • 56名现患哮喘儿童中仅4名三项试验均阳性,24名(43%)三项试验均阴性。

关键数值与推荐

  • NICE算法四项指标:FEV1:FVC<70%、支气管舒张可逆性≥12%、FeNO≥35 ppb、呼气峰流速变异率>20%。
  • 本研究中呼气峰流速变异率数据不可用,仅评估前三项指标。

临床怎么用

  • 对于有喘息、咳嗽或气促等症状的儿童,不宜直接套用NICE肺功能序贯算法诊断哮喘。
  • FEV1:FVC与FeNO或可提供参考,但支气管舒张可逆性在该人群中诊断价值有限。

局限性

  • 呼气峰流速变异率数据不可用,未能完整评估NICE四项算法。
  • 哮喘采用流行病学定义(医生诊断、现患喘息、当前治疗三项均报告),非临床金标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Concerns have been expressed about asthma overdiagnosis. The UK National Institute of Health and Care Excellence (NICE) proposed a new diagnostic algorithm applying four lung function measures sequentially (ratio of forced expiratory volume in 1 s [FEV1] to forced vital capacity [FVC] <70%, bronchodilator reversibility ≥12%, fractional exhaled nitric oxide [FeNO] ≥35 parts per billion, and peak expiratory flow variability >20%). We aimed to assess the diagnostic value of three of the tests individually, and then test the proposed algorithm in symptomatic children. METHODS: We used follow-up data at age 13-16 years from the Manchester Asthma and Allergy Study, a prospective, population-based, birth cohort study. We initially present results for the whole population, then by subgroup of disease. To simulate the situation in primary care, we included participants reporting symptoms of wheeze, cough, or breathlessness in the previous 12 months and who were not on regular inhaled corticosteroids. We used an epidemiological definition of current asthma, defined as all three of physician-diagnosed asthma, current wheeze, and current use of asthma treatment, reported by parents in a validated questionnaire. We assigned children with negative answers to all three questions as non-asthmatic controls. We also measured spirometry, bronchodilator reversibility, and FeNO at follow-up; data for peak expiratory flow variability were not available. We calculated the proportion of participants with a current positive lung function test at each step of the algorithm, and recorded the number of participants that met our definition of asthma. FINDINGS: Of 1184 children born into the cohort, 772 attended follow-up at age 13-16 years between July 22, 2011, and Nov 11, 2014. Among 630 children who completed spirometry, FEV1:FVC was less than 70% in ten (2%) children, of whom only two (20%) had current asthma. Bronchodilator reversibility was positive in 54 (9%) of 624 children, of whom only 12 (22%) had current asthma. FeNO was 35 or more parts per billion in 115 (24%) of 485 children, of whom 29 (25%) had current asthma. Only four of 56 children with current asthma had positive results for all three tests (spirometry, bronchodilator reversibility, and FeNO). Conversely, 24 (43%) of the 56 children with current asthma were negative on all three tests. FEV1:fvc (p=0·0075) and FeNO (p<0·0001), but not bronchodilator reversibility (p=0·97), were independently associated with asthma in multivariable logistic regression models. Among children who reported recent symptoms, the diagnostic accuracy of the algorithm was poor. INTERPRETATION: Our findings challenge the proposed cutoff values for spirometry, the order in which the lung function tests are done, and the position of bronchodilator reversibility within the algorithm sequence. Until better evidence is available, the proposed NICE algorithm on asthma diagnosis should not be implemented in children. FUNDING: UK Medical Research Council.

来源:Lancet Child Adolesc Health,查看原文。版权归原作者所有。

引用

  1. Murray C, Foden P, Lowe L, et al. Diagnosis of asthma in symptomatic children based on measures of lung function: an analysis of data from a population-based birth cohort study. Lancet Child Adolesc Health. 2017. PMID: 29034296. doi:10.1016/S2352-4642(17)30008-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。